Core Viewpoint - The company is actively exploring new technologies in the ophthalmology field, particularly in brain-machine interfaces and AI applications, while maintaining a cautious approach to potential investments and developments [2]. Group 1: Company Performance - As of October 23, 2025, the stock price of He Shi Eye Hospital (301103) closed at 21.15 yuan, with an increase of 0.67%, a turnover rate of 0.78%, a trading volume of 12,400 shares, and a transaction amount of 26.06 million yuan [1]. Group 2: Strategic Developments - The company is focused on the integration of AI and AR technologies in ophthalmology, and is in discussions with leading hardware suppliers and research institutions for potential collaborations [2]. - The company’s affiliate, Shenyang Ailuo Bo Intelligent Technology Co., Ltd., is exploring AI analysis of brain health based on eye position and dynamic pupil data [2]. Group 3: Market Activity - On October 23, the main funds experienced a net outflow of 484,600 yuan, while speculative funds saw a net inflow of 617,500 yuan, and retail investors had a net outflow of 132,900 yuan [2].
股市必读：何氏眼科（301103）10月23日董秘有最新回复